U.S. Department of Health and Human Services
200
U.S. Department of Health and Human Services
200 Independence Avenue SW
Washington, DC 20201
Office of the Assistant Secretary for Preparedness and Response (ASPR) and Biomedical Advanced Research and Development Authority (BARDA):
It is our understanding that Generex Biotechnology is working with the HHS, ASPR, BARDA, and other government agencies to develop the Ii-Key-SARS-CoV-2 peptide vaccine with the goal to begin vaccination in the Fall of 2020. This will require the collection of convalescent plasma for the screening and selection of peptides to be included in the final vaccine formulation. This formulation will then be administered as part of an adaptive design protocol in a clinical trial to assess safety and immunogenicity. Concurrently, a similar clinical trial will be conducted in a special population of healthcare workers. Subsequent special population trials will be conducted in pediatric, geriatric, and immunocompromised populations.
Please accept this letter as notice of our intent to support Generex Biotechnology and BARDA’s efforts to develop the Ii-Key-SARS-CoV-2/COVID-19 vaccine. Although we cannot commit financial support or inkind services at this time, we are eager to provide clinical and laboratory expertise. As resources permit, we are willing to assist in providing convalescent plasma and providing laboratory analysis for vaccine formulation and evaluation of efficacy endpoints for the clinical trials. We recognize the urgent need for vaccine development and are committed to partnering with Generex Biotechnology and BARDA to make it a reality.
Sincerely,
Davey Smith, MD, MAS
1
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Storm Brewing in Healthcare Here's what will make any half-savvy investor's pulse quicken: The Ensign Group, Inc. (NasdaqGS: ENSG) is in hot legal water, and there's a hefty class action floating around with some serious allegations. ClaimsFiler's got the word out, marking December 7, 2026, as the cut-off date for investors wanting to be part of this securities class...
Continue Reading
Storm Clouds Over Fluence Energy I'll tell you, I ain't surprised when companies face the music for dressing up their books. Fluence Energy, Inc. (NASDAQ: FLNC)—those wallopers are now caught in a legal maelstrom with a securities fraud class action lawsuit hanging over their heads. It's hard to feel sorry for 'em when the writing's on the wall. Allegations and...
Continue Reading
Swinging for Luxury in Your Backyard Who'd have thought that a chunk of Austin, Texas, could boast a putting green that’s giving any PGA course a run for its money? We’re talking about a family here who decided they’d had enough of scalding summers and winter chills and wanted a taste of that country club glam at home without the upkeep headaches. The Rise of...
Continue Reading
Millrose Properties: A Storm's Brewing Whoa, step back and take a wide-eyed look at Millrose Properties—there’s a storm brewin’ and it’s a doozy! Right now, they’re up against one mighty class action lawsuit, and investors who’ve been hit for over $100k better circle December 8, 2026, on their calendars if they fancy a shot at lead plaintiff glory. We’re...
Continue Reading
New hires in biotech often get more than just a desk and a computer—they might just snag a piece of the company pie, too. Actinium Pharmaceuticals, the folks dabbling in the mysterious world of targeted radiotherapies, pulled a classic move in welcoming a fresh face to their roster. On October 26, 2026, they rolled out an inducement stock option, a juicy carrot to lure...
Continue Reading
Big Moves After a Tragic Fire Hong Kong's revamping its approach to building maintenance and oversight, clearly in reaction to the horrific Wang Fuk Court blaze last year. That fire didn't just leave scars; it blew open glaring gaps in the city's oversight of building repairs. The government's now jumping into action by launching a raft of measures aimed at preventing...
Continue Reading
Admit it—everyone's got that one fear that sends shivers down their spine. Whether it's the slithering scales of a snake or the manic laughter of a clown, those phobias are what make haunted attractions such a hit for thrillseekers across the country. Amber Arnett-Bequeaith, the so-called Queen of Haunts, knows a thing or two about turning those fears into unforgettable...
Continue Reading
A Paradise Escape Awaits on New Year's Eve Look, I don't know about you, but I've been through enough hurried holiday seasons to appreciate the slower moments when they come. This year's New Year's Eve at Nômade Temple Holbox, dubbed "REVIVAL," promises just that—a sanctuary by the sea to unwind and renewal as we step into 2027. Step into Island Time Located on the...
Continue Reading
End of an Era in Periodontology For those of us who have a stake in the world of dental technology, today hangs heavy. We talk about innovators, pioneers, and game-changers all the time, but Dr. Raymond A. Yukna wasn't just another name on that list - he was the list. The guy practically wrote the book on modern periodontal therapy. With his passing, we're not just saying...
Continue Reading
Wrapping Up a Half-Decay of Environmental Commitment PG&E has been playing the long game with its environmental initiatives, and this wraps up a five-year saga that's worth dissecting. The PG&E Corporation Foundation has doled out its final set of grants, making a 25-strong lineup of eco-friendly campaigns. We're talking $500,000 split among five organizations trying to...
Continue Reading
Top 5 Most Recently Viewed Articles
Botrich Chairman Hong Wei Liao Leads Strategic Delegation Botrich Family Wealth Heritage and Development Center proudly announces that Chairman Hong Wei Liao has successfully led a high-level business delegation as part of the company's strategic initiative to expand global economic opportunities for high-net-worth clients. Pivotal Mission to Central America Recently, Ms....
Continue Reading
Snap Inc. Stock Rises Ahead of Earnings Report Snap Inc (NYSE: SNAP) shares are experiencing an upturn, climbing by 2.9% to $10.75 during the latest trading session. This positive movement occurs just before the company is set to unveil its third-quarter financial results. Analysts and investors alike are keenly observing Snap's performance, especially following the mixed...
Continue Reading
The Legacy of a Pharma Powerhouse Recognizing a titan in the pharmaceutical realm, Marquis Who's Who chose to celebrate Shawn Patrick O'Brien, honoring his extensive contributions to the industry. With roots stretching back over four decades, O'Brien's name is synonymous with pioneering innovation and strategic acumen in the pharmaceutical and biotech spheres. Charting...
Continue Reading
Introducing the HETTINGER INVENTION for Improved Measurements In the world of construction and home improvement, having the right tools is essential for ensuring precise work. One inventor recognized a gap in traditional tape measure designs and has taken it upon themselves to innovate. The result is the HETTINGER INVENTION, a modified tape measure designed for enhanced...
Continue Reading
Barney's Farm Exits Proposed Merger with PowerPlant, Inc. Barney's Farm, a renowned leader in cannabis seed breeding, has announced the immediate termination of its proposed merger with PowerPlant, Inc. Derry Brett, the founder of Barney's Farm, articulated significant concerns about investor trust and the integrity of the brand's legacy, which drove this decision....
Continue Reading